|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
An Oncology Physical Therapist Explains Why Movement Matters Most During Cancer Treatment
2
Top 5 Takeaways From EHA 2026 That Patients Should Know
3
FDA Expands Tecelera Approval to Include Patients as Young as 12 With Advanced Synovial Sarcoma
4
When a Routine Cancer Screening Stops Being Routine
5